|
|
Volumn 170, Issue 5, 1999, Pages 240-
|
|
Should smoking be an indication for lipid-lowering therapy? [7]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
CHOLESTEROL;
ADULT;
AGED;
AUSTRALIA;
CARDIOVASCULAR DISEASE;
CHOLESTEROL BLOOD LEVEL;
COST EFFECTIVENESS ANALYSIS;
HUMAN;
LETTER;
PRACTICE GUIDELINE;
RISK FACTOR;
SMOKING;
|
|
EID: 0033105534
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.1999.tb140342.x Document Type: Letter |
|
Times cited : (1)
|
|
References (6)
|
